Therapeutic drug monitoring of infliximab and mucosal healing in inflammatory bowel disease: a prospective study

Data on the value of therapeutic drug monitoring of infliximab (IFX) to predict mucosal healing (MH) in inflammatory bowel diseases (IBD) are scarce. All consecutive patients with IBD receiving ongoing IFX (5 mg/kg) treatment and developing secondary failure to IFX were enrolled in a prospective stu...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Inflammatory bowel diseases 2013-11, Vol.19 (12), p.2568-2576
Hauptverfasser:	Paul, Stephane, Del Tedesco, Emilie, Marotte, Hubert, Rinaudo-Gaujous, Melanie, Moreau, Amelie, Phelip, Jean-Marc, Genin, Christian, Peyrin-Biroulet, Laurent, Roblin, Xavier
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antibodies, Monoclonal - therapeutic use Biomarkers - analysis Colitis, Ulcerative - drug therapy Crohn Disease - drug therapy Cross-Sectional Studies Drug Monitoring Female Follow-Up Studies Gastrointestinal Agents - therapeutic use Humans Infliximab Male Mucous Membrane - drug effects Prognosis Prospective Studies Remission Induction Wound Healing - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!